drugset / Trial / NCT05102006
A Phase Ib/II Clinical Study of LBL-007 in Combination With Toripalimab in Treatment of Advanced Malignant Tumors
NaSingle-groupOpen-labelTreatment
Summary
This is a single-arm, open-label, multicenter Phase Ib/II clinical study to evaluate the safety, tolerability, PK characteristics, immunogenicity and efficacy of LBL-007 in combination with Toripalimab in Treatment of Advanced Malignant Tumors.
Timeline
- Start
- 2021-11-30
- Primary completion
- 2024-05-22
- Completion
- 2024-05-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alcestobart | Monoclonal antibody | — | Intravenous |
| Subject | Toripalimab | Monoclonal antibody | — | Intravenous |